Literature DB >> 12091061

Alveolar soft part sarcoma. a report of 15 cases.

S van Ruth1, F van Coevorden, J L Peterse, B B R Kroon.   

Abstract

The aim of this study was to evaluate the presentation, course and treatment outcome of 15 patients with this rare type of sarcoma. The files of the patients were retrospectively analysed. Overall survival was calculated according to the Kaplan-Meier method. There were 15 patients, 8 male and 7 female. The mean age at diagnosis was 29 years for men and 24 years for women. The median survival was 48 months with an overall 5-year survival of 38%. 5 patients had haematogenic metastases at the time of diagnosis. For the remaining 10 patients with localised disease, the median survival was 48 months and the 5-year survival 48%. The median disease-free survival for these patients was 12 months with a 5-year disease free survival of 40%. After the occurrence of haematogenic metastases, patients survived a median period of 8 months (range 0-45 months). 5 patients are still free of disease after a median period of 234 months (12-295 months). Alveolar soft part sarcoma is found especially in young adults. When diagnosed, it is often metastasised with a poor prognosis. However, when radically resected, long-term survival is possible.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12091061     DOI: 10.1016/s0959-8049(02)00032-1

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  11 in total

1.  A retrospective analysis of lung metastasis in 64 patients with alveolar soft part sarcoma.

Authors:  Y-P Liu; J Jin; W-H Wang; S-L Wang; Y-W Song; H Fang; H Ren; X-F Liu; Z-H Yu; Y-X Li
Journal:  Clin Transl Oncol       Date:  2015-06-03       Impact factor: 3.405

2.  Alveolar soft part sarcoma of the larynx.

Authors:  Tahir Altuğ; Ender Inci; Melih Güven Güvenç; Deniz Tuna Edizer; Sergülen Dervişoğlu
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-10-25       Impact factor: 2.503

Review 3.  Primary alveolar soft part sarcoma of the uterine cervix: a case report and literature review.

Authors:  Min Feng; Wei Jiang; Yanmei He; Lei Li
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

4.  Alveolar soft part sarcoma: a single-center 26-patient case series and review of the literature.

Authors:  Koichi Ogura; Yasuo Beppu; Hirokazu Chuman; Akihiko Yoshida; Noboru Yamamoto; Minako Sumi; Hirotaka Kawano; Akira Kawai
Journal:  Sarcoma       Date:  2012-05-15

5.  Adult alveolar soft part sarcoma of the head and neck: a report of two cases and literature review.

Authors:  Brandon T Mullins; Trevor Hackman
Journal:  Case Rep Oncol Med       Date:  2014-12-23

6.  Primary alveolar soft part sarcoma of the right femur and primary lymphoma of the left femur: A case report and literature review.

Authors:  Yiyuan Cao; Hanfei Zhang; Yanjuan Qu; Meiyan Liao
Journal:  Oncol Lett       Date:  2015-11-10       Impact factor: 2.967

7.  Primary Intracerebral Alveolar Soft Part Sarcoma in an 11-Year-Old Girl: Case Report and Review of the Literature.

Authors:  Hakan Emmez; Aydemir Kale; Çelik Sevinç; Alp Özgün Börcek; Güldal Yilmaz; Memduh Kaymaz; Ömer Uluoğlu; Aydın Paşaoğlu
Journal:  NMC Case Rep J       Date:  2014-09-29

8.  Resection of pancreatic and splenic metastases from alveolar soft part sarcoma: a case report.

Authors:  Satoshi Arakawa; Yukio Asano; Norihiko Kawabe; Hidetoshi Nagata; Yuka Kondo; Shinpei Furuta; Masahiro Shimura; Chihiro Hayashi; Takayuki Ochi; Kenshiro Kamio; Toki Kawai; Hironobu Yasuoka; Takahiko Higashiguchi; Shin Ishihara; Masahiro Ito; Yoshihiro Imaeda; Akihiko Horiguchi
Journal:  Surg Case Rep       Date:  2020-06-17

9.  Alveolar soft-part sarcoma responding to interferon alpha-2b.

Authors:  K J Roozendaal; B de Valk; J J A ten Velden; H J van der Woude; B B R Kroon
Journal:  Br J Cancer       Date:  2003-07-21       Impact factor: 7.640

10.  Magnetic resonance imaging features of alveolar soft part sarcoma: report of 14 cases.

Authors:  Xubin Li; Zhaoxiang Ye
Journal:  World J Surg Oncol       Date:  2014-02-11       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.